Parkinson's disease (PD) is characterized by progressive and selective loss of dopaminergic neurons in substantia nigra pars compacta. Emerging evidence suggests that the degeneration of dopaminergic neurons in PD is mediated via mitochondrial dysfunction and subsequent activation of various apoptosis-execution cascades. Thus, the long-term goal of this proposal is to identify novel neuroprotective agents that are capable of blocking the mitochondrial apoptosis-signaling pathway in dopaminergic neurons induced by Parkinsonian neurotoxins. HSP27 is a member of the small heat shock protein family, a group of ubiquitous stress proteins that are expressed in virtually all organisms. The expression of HSP27 is induced in the brain after several forms of injury, and its neuroprotective role has been strongly implicated. In addition to its knovm function as a protein chaperone, recent studies suggest that HSP27 has potent anti-apoptotic effects, and it appears that HSP27 gains its anti-apoptotic properties after undergoing serine-specific phosphorylation. We have recently created transgenic mice overexpressing either the wild-type HSP27 or a nonphosphorylatable HSP27 mutant. Using both transgenic and gene-transfection approaches, we have obtained exciting preliminary results which suggest that overexpression of HSP27 protects against dopaminergic cell death induced by PD-relevant insults in both in vivo and in vitro settings, that the neuroprotective effect of HSP27 is dependent on phosphorylation-mediated activation of the protein, and that HSP27 may achieve the neuroprotective effect via inhibiting ASKi/JNK-mediated mitochondrial-apoptosis signaling pathway. This proposal attempts to test the hypothesis that enhanced expression and phosphorylationdependent activation of HSP27 protects against dopaminergic cell death via novel antiapoptotic mechanisms. The following specific objectives are proposed:
Aim 1. Test the hypothesis that transgenic overexpression and phosphorylation-dependent activation of HSP27 protects against dopaminergic cell death in the brain following Parkinsonian neurotoxins.
Aim 2. Test the hypothesis that the neuroprotective effect of HSP27 against dopaminergic cell death is mediated via novel anti-apoptotic mechanisms involving the disruption of ASKi/JNK-dependent mitochondrial signaling pathways.
Aim 3. Test the hypothesis that TAT protein transduction domain-mediated or adeno-associated virus (AAV)-mediated delivery of HSP27 into the brain protects against dopaminergic cell death induced by Parkinsonian neurotoxins. Studies in both in vivo and in vitro models are proposed. The in vivo animal models of 6-OHDA and rotenone neurotoxicity mimics important aspects of pathophysiological changes in relevance to PD. The in vitro models employing various Parkinsonian neurotoxins (6-OHDA, MPP-t-, rotenone) will complement the in vivo studies by allowing for precise mechanistic studies to be performed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS059806-05
Application #
8505552
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
5
Fiscal Year
2013
Total Cost
$189,694
Indirect Cost
$64,484
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
An, Chengrui; Shi, Yejie; Li, Peiying et al. (2014) Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair. Prog Neurobiol 115:6-24
Tapias, Victor; Greenamyre, J Timothy (2014) A rapid and sensitive automated image-based approach for in vitro and in vivo characterization of cell morphology and quantification of cell number and neurite architecture. Curr Protoc Cytom 68:12.33.1-12.33.22
Mohammadyani, Dariush; Tyurin, Vladimir A; O'Brien, Matthew et al. (2014) Molecular speciation and dynamics of oxidized triacylglycerols in lipid droplets: Mass spectrometry and coarse-grained simulations. Free Radic Biol Med 76:53-60
Hu, Xiaoming; Liou, Anthony K F; Leak, Rehana K et al. (2014) Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles. Prog Neurobiol 119-120:60-84
Tapias, Victor; Cannon, Jason R; Greenamyre, J Timothy (2014) Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease. Neurobiol Aging 35:1162-76
Sanders, Laurie H; McCoy, Jennifer; Hu, Xiaoping et al. (2014) Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease. Neurobiol Dis 70:214-23
Sanders, Laurie H; Laganiere, Josee; Cooper, Oliver et al. (2014) LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction. Neurobiol Dis 62:381-6
Wang, Jiayin; Shi, Yejie; Zhang, Lili et al. (2014) Omega-3 polyunsaturated fatty acids enhance cerebral angiogenesis and provide long-term protection after stroke. Neurobiol Dis 68:91-103
Tapias, Victor; Greenamyre, J Timothy; Watkins, Simon C (2013) Automated imaging system for fast quantitation of neurons, cell morphology and neurite morphometry in vivo and in vitro. Neurobiol Dis 54:158-68
Sanders, Laurie H; Greenamyre, J Timothy (2013) Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radic Biol Med 62:111-20

Showing the most recent 10 out of 28 publications